Transocean Ltd vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Transocean Ltd trades at $5.51 (market cap $6.19B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 4.1× Transocean Ltd's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Transocean Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Transocean Ltd for 18 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| RIG | RPRX | |
|---|---|---|
Market Cap | $6.19B | $25.27B |
Volume | 30,564,415 | 3,671,183 |
Sector | Energy | Health |
52-Week High | $7.58 | $63.96 |
52-Week Low | $3.08 | $35.44 |
Typical Hold Time | 18 Days | 1 Days |
Enterprise Value | $10.80B | $32.50B |
Dividend Yield | — | 1.66% |
Signals from Pluang's Aura AI — not financial advice
Transocean (RIG) trades at $5.54, up 2.78% today, showing bullish technical momentum with strong cash flow generation despite negative earnings. The company maintains a robust contract backlog with recent $80M and $300M deals, while the $5.8B Valaris acquisition advances after DOJ approval. Valuation metrics show attractive P/B of 0.74 and P/S of 1.45, though profitability remains challenged with -40.24% net margin.
RIG presents a speculative opportunity with improving operational cash flow supporting deleveraging efforts, but high debt levels and execution risks around major acquisitions pose significant challenges. Analyst sentiment is divided with 39% buy ratings, reflecting the balance between offshore drilling recovery potential and financial risk exposure.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →